Samil Pharmaceutical Co.,Ltd
000520.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$178.44B
Close$
Share Statistics
| Market cap | $178.44 Billion |
|---|---|
| Enterprise Value | $348.40 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1627.95 |
| Beta | 0.34 |
| Outstanding Shares | 21,371,000 |
Return
| Return on Equity | -29.90% |
|---|---|
| Return on Assets | -10.02% |
| Return on Invested Capital | -14.19% |
Valuation & Multiples
| P/E Ratio | -4.73 |
|---|---|
| PEG | -25.8 |
| Price to Sales | 0.84 |
| Price to Book Ratio | 1.39 |
| Enterprise Value to Revenue | 1.68 |
| Enterprise Value to EBIT | -11.46 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | 1.4 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Samil Pharmaceutical Co.,Ltd
585 employees
CEO: Seung Bum Huh Samil Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company founded in 1947 that develops, manufactures, and sells a range of healthcare products. While its portfolio includes various medicines and medical devices, it has a p...